Avanos Medical (AVNS) Short term Debt (2013 - 2026)

Avanos Medical has disclosed Short term Debt across 9 years of filings, most recently posting $10.9 million for Q1 2026.

• Short term Debt for Q1 2026 came in at $10.9 million, up 15.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.9 million (up 15.96% YoY), and the FY2025 annual result was $10.2 million, up 8.51% from the prior year.
• Short term Debt came in at $10.9 million for Q1 2026 at Avanos Medical, up from $10.2 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $10.9 million in Q1 2026 to a low of $4.7 million in Q2 2022.
• The 5-year median for Short term Debt is $9.4 million (2024), against an average of $8.2 million.
• Across the five-year window, Short term Debt surged 64.52% in 2024 and declined 7.84% in 2025, its largest moves.
• Avanos Medical's Short term Debt stood at $6.2 million in 2022, then jumped by 38.71% to $8.6 million in 2023, then increased by 9.3% to $9.4 million in 2024, then advanced by 8.51% to $10.2 million in 2025, then gained by 6.86% to $10.9 million in 2026.
• The last three Short term Debt figures came in at $10.9 million (Q1 2026), $10.2 million (Q4 2025), and $9.4 million (Q3 2025), per Business Quant data.